CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 10,985 shares (grant or award)
- 4 Grant or award Director acquired 43,940 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Planned sale Director sold 41,760 shares at an average $223.50 ($9,333,272)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,990,603 shares (to pay taxes)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- F-6/A Other F-6/A
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- F-6 Other Registration of American Depositary Receipt Shares
- 4 Planned sale Director sold 41,760 shares at an average $242.66 ($10,133,595)
Page 13 of 64 · 1,278 filings